IMMUNOTHERAPY EXPANDED ACCESS - WHAT YOU NEED TO KNOW
In Partnership with The Limbic LIVE
With multi-indication PBS listing widening immunotherapy access for advanced and metastatic cancers, ‘clinical judgement and discretion’ takes on new meaning for oncologists. These webinars will help you navigate this game-changing development, guiding you through the evidence and offering practical pointers to support personalised treatment decision making.
All webinars will feature expert panel discussion and opportunities to ask questions.
What this means for us, our patients and the health system
Thursday 30th April 2026 | 7:30pm - 9:00pm (AEST)
Hosted by A/Prof James Lynam
Defining ‘immunotherapy sensitive’
Thursday 21st May 2026 | 7:30pm - 9:00pm (AEST)
Hosted by A/Prof Jenny Liu
Navigating ‘immunotherapy resistant’
Wednesday 10th June 2026 | 7:30pm - 9:00pm (AEST)
Hosted by A/Prof James Lynam
These webinars are supported by unrestricted educational grants and created independently by the Medical Oncology Group of Australia (MOGA) in collaboration with the limbic. All content is selected by the participants and all views expressed are those of the participants only.
Target Audience
Medical oncologists, early career Young Oncologists and Advanced Trainees. Registration is open to MOGA members and non-members.
sponsors
